Added to YB: 2025-07-07
Pitch date: 2025-05-19
XGN [bullish]
Exagen Inc.
+55.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Market Cap
$212.8M
Pitch Price
$6.34
Price Target
18.00 (+85%)
Dividend
N/A
Sector
Biotechnology
Category
turnaround
Show full summary:
Exagen Inc. - $XGN
XGN: Molecular diagnostics co for autoimmune diseases. AVISE CTD test 2x more effective than standard care, reducing diagnosis time from 6 years, saving costs. Near breakeven after $35M annual burn. New CEO (sold previous cos), joined by proven turnaround CFO. 1.9x revenue vs peers 4.4x. 20%+ rev CAGR path, profitable by Q4 2025. $16-18 PT (2.5-3x upside).
Read full article (7 min)